Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. (WSE:VOX) for PLN 11 million on September 21, 2012. Enterprise Investors already made an upfront payment of PLN 5 million, with the remainder payable at a later date, subject to certain conditions. Enterprise Investors will finance the development of the radiotherapy center in cooperation with a private company and a medical university.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.4 PLN | +1.07% | +2.61% | +20.10% |
03-11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
2023 | Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.10% | 253M | |
-23.07% | 7.86B | |
+68.36% | 4.32B | |
+1.88% | 2.63B | |
-8.06% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.18% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B |
- Stock Market
- Equities
- VOX Stock
- News Voxel S.A.
- Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million.